OraSure Technologies Inc (OSUR)
3.92
-0.11
(-2.73%)
USD |
NASDAQ |
Jul 05, 15:15
OraSure Technologies SG&A Expense (TTM): 84.74M for March 31, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 84.74M |
December 31, 2023 | 94.51M |
September 30, 2023 | 100.91M |
June 30, 2023 | 111.12M |
March 31, 2023 | 115.42M |
December 31, 2022 | 117.44M |
September 30, 2022 | 117.70M |
June 30, 2022 | 115.08M |
March 31, 2022 | 107.23M |
December 31, 2021 | 95.08M |
September 30, 2021 | 88.85M |
June 30, 2021 | 80.42M |
March 31, 2021 | 79.41M |
December 31, 2020 | 77.11M |
September 30, 2020 | 75.25M |
June 30, 2020 | 73.81M |
March 31, 2020 | 68.35M |
December 31, 2019 | 67.16M |
September 30, 2019 | 65.82M |
June 30, 2019 | 63.14M |
March 31, 2019 | 64.27M |
December 31, 2018 | 68.93M |
September 30, 2018 | 65.33M |
June 30, 2018 | 65.60M |
March 31, 2018 | 64.77M |
Date | Value |
---|---|
December 31, 2017 | 57.85M |
September 30, 2017 | 58.99M |
June 30, 2017 | 58.23M |
March 31, 2017 | 56.73M |
December 31, 2016 | 58.01M |
September 30, 2016 | 57.48M |
June 30, 2016 | 60.75M |
March 31, 2016 | 61.98M |
December 31, 2015 | 60.58M |
September 30, 2015 | 62.16M |
June 30, 2015 | 60.38M |
March 31, 2015 | 61.65M |
December 31, 2014 | 64.87M |
September 30, 2014 | 65.30M |
June 30, 2014 | 64.79M |
March 31, 2014 | 65.92M |
December 31, 2013 | 68.12M |
September 30, 2013 | 67.47M |
June 30, 2013 | 66.97M |
March 31, 2013 | 64.72M |
December 31, 2012 | 59.40M |
September 30, 2012 | 54.47M |
June 30, 2012 | 52.90M |
March 31, 2012 | 47.25M |
December 31, 2011 | 42.71M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
65.82M
Minimum
Sep 2019
117.70M
Maximum
Sep 2022
91.34M
Average
88.85M
Median
Sep 2021
SG&A Expense (TTM) Benchmarks
Integra Lifesciences Holdings Corp | 655.78M |
Insulet Corp | 771.90M |
Perspective Therapeutics Inc | 19.11M |
Xtant Medical Holdings Inc | 72.60M |
Asensus Surgical Inc | 34.07M |